Andrew Witty
|
This article is part of the Pharma_Portal project of Spinwatch. |
Sir Andrew Witty is the chief executive officer of GlaxoSmithKline plc.
Career
Witty joined GSK in 1985, he's worked in the Uk, South Africa, the USA and Singapore in various senior roles. In 2003 he was appointed president of GSK Europe and joined GSK's corporate executive team. He was appointed CEO on 21 May 2008 and is a member of the board.[1]
Affiliations
- UK Prime Minister's Business Advisory Group, member.
- Global Health Innovation, member of the advisory board
- University of Nottingham, chancellor
- UK Business Ambassador Group[1]
Former affiliations
- Department for Business, Innovation and Skills, lead non-executive board member until December 2013.
- European Federation of Pharmaceutical Industries and Associations, president until June 2013[1]
Honours
- Knighted in 2012 New Years Honours list for services to the economy and to the UK pharmaceutical industry.
- Awarded the Public Service Medal by the Government of Singapore 2003 and the Public Service Star in August 2012.[1]
Notes
- ↑ 1.0 1.1 1.2 1.3 GlaxoSmithKline Sir Andrew Witty, accessed 14 April 2015.
